| Officer | Age | 2025 pay | Source |
|---|---|---|---|
|
Leon O. Moulder, Jr.
Also a director
See Remarks
Title from the Form 4 dated Jun 15, 2026
|
68 | $4,661,000 | |
|
Joseph L. Farmer
See Remarks
Title from the Form 4 dated Jun 15, 2026
|
54 | $2,526,525 | |
|
Jennifer Fox
See Remarks
Title from the Form 4 dated Jun 15, 2026
|
54 | Not reported | |
|
Lisa von Moltke
See Remarks
Title from the Form 4 dated Jun 15, 2026
|
67 | $3,499,447 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Mar 16, 2026 · updated by the 8-Ks of May 13, 2026 and Aug 13, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
Leon O. Moulder, Jr.
CEO, Board chair
|
68 |
2020
6 years
|
Not stated | None stated | Zai Lab Ltd. | Paid as CEO | |
|
James Boylan
Lead independent director
|
58 |
2022
4 years
|
Not stated |
Audit Committee
Compensation Committee
|
Immunome Therapeutics Inc. | $241,873 | |
|
Hongbo Lu
|
55 |
2022
4 years
|
Not stated |
Nominating Committee
Science Committee
|
Arrowhead Pharmaceuticals | Not stated | |
|
Patrick Enright
|
64 |
2022
4 years
|
Not stated |
Audit Committee
Compensation Committee
|
Veradermics, Incorporated, Vera Therapeutics, Inc. | $225,023 | |
|
Patricia Allen
|
64 |
2024
2 years
|
Not stated |
Audit Committee · Chair
|
None stated | $229,023 | |
|
Jake Nunn
|
55 |
2024
2 years
|
Not stated |
Nominating and Corporate Governance Committee · Chair
|
Addex Therapeutics Ltd. | $219,023 | |
|
John Orloff
|
68 |
2022
4 years
|
Not stated |
Compensation Committee · Chair
Science and Technology Committee · Chair
|
None stated | $226,875 | |
|
Christy J. Oliger
Joined Sep 1, 2026
|
- | - | Independent |
Nominating and Corporate Governance Committee
Science and Technology Committee
|
- | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
The proxy filed Mar 16, 2026 describes a review policy but reports no transactions.
Read the policy in the proxyLoading...